Skip to main content
Premium Trial:

Request an Annual Quote

Greifswald to Use InforSense Software for Genotyping Study

NEW YORK (GenomeWeb News) – InforSense said today that the University of Greifswald is using its GenSense software platform to handle quality control, analysis, and annotation for a genotyping study of the causes of various diseases.

The University, located in Germany's Baltic Sea region, will use the software to analyze data from study of 4,100 individuals who were genotyped with the Affymetrix Genome-Wide Human SNP Array 6.0.

The Study of Health in Pomerania, which includes phenotype data, is aimed at finding the genetic causes of complex diseases, including the susceptibility loci for several common diseases.

The GenSense platform enables customers to "automate their genotypic analysis and quality control and improve productivity, especially when data needs to be repeatedly reformatted and transformed for use with different studies and tools," Jonathan Sheldon, InforSense's chief scientific officer, said in a statement.

Financial terms of the agreement were not released.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.